Méthodes sémantiques pour la comparaison inter-espèces de voies métaboliques (application au métabolisme des lipides chez l'humain, la souris et la poule)

La comparaison inter-espèces de voies métaboliques est une problématique importante en biologie. Actuellement, les connaissances sont générées à partir d'expériences sur un nombre relativement limité d'espèces dites modèles. Mieux connaître une espèce permet de valider ou non une inférence faite à partir de ces données expérimentales et de déterminer si ou dans quelle mesure des résultats obtenus sur une espèce modèle peuvent être transposés à une autre espèce. Cette thèse propose une méthode de comparaison inter-espèces de voies métaboliques. Elle compare chaque étape d'une voie métabolique en exploitant les annotations dans Gene Ontology qui leur sont associées. Ce travail valide l'intérêt des mesures de similarités sémantiques pour interpréter ces annotations, propose d'utiliser conjointement une mesure de particularité sémantique et propose une méthode basée sur des motifs de similarité et de particularité pour interpréter chaque étape de voie métabolique. De nombreuses mesures sémantiques quantifient la similarité entre des produits de gènes en fonction des annotations qu'ils ont en commun. Nous en avons identifié et utilisé une adaptée à la problématique de comparaison inter-espèces. En se focalisant sur la part commune aux produits de gènes comparés, les mesures de similarité sémantiques ignorent les caractéristiques spécifiques d'un seul produit de gène. Or la comparaison inter-espèces de voies métaboliques se doit de quantifier non seulement la similarité des produits de gènes qui interviennent dans celles-ci, mais également leurs particularités. Nous avons développé une mesure de particularité sémantique répondant à cette problématique. Pour chaque étape de voie métabolique, nous calculons un profil composé de sa valeur de similarité et de ses deux valeurs de particularité sémantiques. Il n'est pas possible d'établir formellement que deux produits de gènes sont similaires ou que l'un d'eux a des particularités significatives sans disposer d'un seuil de similarité et d'un seuil de particularité. Jusqu'à présent, ces interprétations se faisaient sur la base d'un seuil implicite ou arbitraire. Pour combler ce manque, nous avons développé une méthode de définition de seuils pour les mesures de similarité et de particularité sémantiques. Nous avons enfin appliqué une mesure de similarité inter-espèces et notre mesure de particularité pour comparer le métabolisme des lipides entre l'Homme, la souris et la poule. Nous avons pu interpréter les résultats à l'aide des seuils que nous avions définis. Chez les trois espèces, des particularités ont pu être observées, y compris au niveau de produits de gènes similaires. Elles concernent notamment des processus biologiques et des composants cellulaires. Les fonctions moléculaires présentent une forte similarité et peu de particularités. Ces résultats sont biologiquement pertinents.Cross-species comparison of metabolic pathways is an important task in biology. It is a major stake for both human health and agronomy. Currently, knowledge is acquired from some experiments on a relatively low number of species referred to as models''. A better understanding of a species determines whether to validate or not an inference made from these experimental data. It also determines whether or to what extent results obtained on model species can be transposed to another species. This thesis proposes a cross-species metabolic pathways comparison method. Our method compares each step of a metabolic pathway using the associated Gene Ontology annotations. This work validates the interest of the semantic similarity measures for interpreting these annotations, proposes to use jointly a semantic particularity measure and proposes a method based on similarity and particularity patterns to interpret each metabolic pathway step. Several gene products are involved throughout a metabolic pathway. They are associated to some annotations in order to describe their biological roles. Based on a shared ontology, these annotations allow to compare data from different species and to take into account several level of abstraction. Several semantic measures quantifying the similarity between gene products from their annotations have been developed previously. We have identified and used a semantic similarity measure appropriate for cross-species comparisons. Because they focus on the common part of the compared gene products, the semantic similarity measures ignore their specific characteristics. Therefore, cross-species metabolic pathways comparison has to quantify not only the similarity of the gene products involved, but also their particularity. We have developed a semantic particularity measure addressing this issue. For each pathway step, we proposed to create a profile combining its semantic similarity and its two semantic particularity values. Concerning the results interpretation, it is not possible to establish formally that two gene products are similar or that one of them have some significant particularities without having a similarity threshold and a particularity threshold. So far, these interpretations were based on an implicit or an arbitrary threshold. To address this gap, we developed a threshold definition method for the semantic similarity and particularity measures. We last applied a cross-species similarity measure and our particularity measure to compare the lipid metabolism between human, mice and chicken. We then interpreted the results using the previously defined thresholds. In all three species, we observed some particularities, including on similar genes. They concerned notably some biological processes and cellular components. The molecular functions present a strong similarity and few particularities. These results are biologically relevant.RENNES1-Bibl. électronique (352382106) / SudocSudocFranceF

Tailored Protocol Development Using ESTEREL

The rapid evolution of networking and the multiplication of new applications re-emphasizes the importance of the efficient communication supports. Implementations must be able to take maximal advantage of the details of application-specific semantics and of specific networking environments. In other words, the application needs to have more control over data transmission. Such control can be obtained by tailoring the communication facilities (or protocols) to the application characteritics, and by integrating the communication control to the application. Because such a task is too complex to be realized manually, we propose to automate the protocol development process using a formal approach. This report presents our approach to the automated design and implementation of application- specific communication protocols based on information provided by the application. Starting from the formal description of an application, our approach is based on a tool called "Protocol Compiler" that will automatically produce the implementation of a communication protocol tailored to the application. The formalism we use is ESTEREL, a synchronous reactive language dedicated to the description of real-time systems. Protocol description and verification using ESTEREL are described, as well as protocol optimization and implementation principles

Transcriptome profiling of the feeding-to-fasting transition in chicken liver

<p>Abstract</p> <p>Background</p> <p>Starvation triggers a complex array of adaptative metabolic responses including energy-metabolic responses, a process which must imply tissue specific alterations in gene expression and in which the liver plays a central role. The present study aimed to describe the evolution of global gene expression profiles in liver of 4-week-old male chickens during a 48 h fasting period using a chicken 20 K oligoarray.</p> <p>Results</p> <p>A large number of genes were modulated by fasting (3532 genes with a pvalue corrected by Benjamini-Hochberg < 0.01); 2062 showed an amplitude of variation higher than +/- 40% among those, 1162 presented an human ortholog, allowing to collect functional information. Notably more genes were down-regulated than up-regulated, whatever the duration of fasting (16 h or 48 h). The number of genes differentially expressed after 48 h of fasting was 3.5-fold higher than after 16 h of fasting. Four clusters of co-expressed genes were identified by a hierarchical cluster analysis. Gene Ontology, KEGG and Ingenuity databases were then used to identify the metabolic processes associated to each cluster. After 16 h of fasting, genes involved in ketogenesis, gluconeogenesis and mitochondrial or peroxisomal fatty acid beta-oxidation, were up-regulated (cluster-1) whereas genes involved in fatty acid and cholesterol synthesis were down-regulated (cluster-2). For all genes tested, the microarray data was confirmed by quantitative RT-PCR. Most genes were altered by fasting as already reported in mammals. A notable exception was the <it>HMG-CoA synthase 1 </it>gene, which was up-regulated following 16 and 48 h of fasting while the other genes involved in cholesterol metabolism were down-regulated as reported in mammalian studies. We further focused on genes not represented on the microarray and candidates for the regulation of the target genes belonging to cluster-1 and -2 and involved in lipid metabolism. Data are provided concerning PPARa, SREBP1, SREBP2, NR1H3 transcription factors and two desaturases (FADS1, FADS2).</p> <p>Conclusion</p> <p>This study evidences numerous genes altered by starvation in chickens and suggests a global repression of cellular activity in response to this stressor. The central role of lipid and acetyl-CoA metabolisms and its regulation at transcriptional level are confirmed in chicken liver in response to short-term fasting. Interesting expression modulations were observed for <it>NR1H3, FADS1 </it>and <it>FADS2 </it>genes. Further studies are needed to precise their role in the complex regulatory network controlling lipid metabolism.</p

Development and validation of high-density SNP array in ducks

Development and validation of high-density SNP array in ducks. XIth European symposium on poultry genetics (ESPG

Nouvelles données sur la séquence aurignacienne de la grotte d'Isturitz (communes d'Isturitz et de Saint-Martin-d'Arberoue. Pyrénées-Atlantiques)

Isturitz Cave is located in the western Pyrenees in the heart of the zone of passage and contact between the Aquitaine region and the Vasco-Cantabrian ledge. Excavations during the first half of the 20th century yielded a remarkable archaeological sequence covering the Middle Palaeolithic and the entire Upper Palaeolithic. New research conducted in the Saint-Martin chamber has revealed intensive Aurignacian occupations attributed to the archaic and early phases of this techno-complex. In this paper, we present a synthesis of the principal data that make Isturitz a key site in the study of this period.Située dans les Pyrénées occidentales, au coeur de la zone de passage et de contact entre l'Aquitaine et la corniche vasco-cantabrique, la grotte d'Isturitz a fait l'objet, dans la première moitié du XXe siècle, de fouilles qui ont livré un remarquable ensemble archéologique couvrant le Paléolithique moyen et la quasi-totalité du Paléolithique supérieur. De nouvelles recherches menées dans la salle de Saint-Martin ont mis en évidence d'importantes occupations aurignaciennes attribuées aux phases archaïques et anciennes de ce technocomplexe. Nous ferons dans cet article une synthèse des principales données qui font de la grotte d'Isturitz un site clef pour l'étude de celles-ci

Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature survey.

AIMS: A descriptive survey of published population pharmacokinetic and/or pharmacodynamic (PK/PD) analyses from 2002 to 2004 was conducted and an evaluation made of how model building was performed and reported. METHODS: We selected 324 articles in Pubmed using defined keywords. A data abstraction form (DAF) was then built comprising two parts: general characteristics including article identification, context of the analysis, description of clinical studies from which the data arose, and model building, including description of the processes of modelling. The papers were examined by two readers, who extracted the relevant information and transmitted it directly to a MySQL database, from which descriptive statistical analysis was performed. RESULTS: Most published papers concerned patients with severe pathology and therapeutic classes suffering from narrow therapeutic index and/or high PK/PD variability. Most of the time, modelling was performed for descriptive purposes, with rich rather than sparse data and using NONMEM software. PK and PD models were rarely complex (one or two compartments for PK; E(max) for PD models). Covariate testing was frequently performed and essentially based on the likelihood ratio test. Based on a minimal list of items that should systematically be found in a population PK-PD analysis, it was found that only 39% and 8.5% of the PK and PD analyses, respectively, published from 2002 to 2004 provided sufficient detail to support the model-building methodology. CONCLUSIONS: This survey allowed an efficient description of recent published population analyses, but also revealed deficiencies in reporting information on model building

Pyroséquençage pour le développement d'EST et de SNP aviaires

Le but du programme est de combler les déficits en marqueurs observés pour trois espèces aviaires : la caille, le canard et la poule. La stratégie choisie est l'obtention, à partir de plusieurs individus de lignées d'intérêt, de SNP (Single Nucleotide Polymorphism, polymorphisme d'un nucléotide) par une nouvelle technologie de séquençage à haut débit (séquenceur 454 GS-FLX, Roche). Nous séquençons des représentations réduites du génome, en sélectionnant d'une part des fragments de restriction d'ADN génomique - les mêmes chez tous les individus - et d'autre part les transcrits qui représentent globalement la partie du génome correspondant aux gènes exprimés. Ces expérimentations sont réalisées à partir d'échantillons d'ADN ou d'ARN issus d'individus de lignées à l'origine de croisements existants, pour chacune des trois espèces. Les données générées par plusieurs "runs" de séquence seront traitées in silico : contigage à haut débit, recherche de SNP, comparaison avec les banques de séquences connues...En plus de l'intérêt que représente la production d'un très grand nombre de SNP nouveaux, cette technologie devrait permettre de mieux séquencer les régions riches en (G+C) correspondant aux plus petits des microchromosomes pour lesquels il n'y a pas de séquence chez la poule. La comparaison des séquences des transcrits obtenues chez la caille et le canard avec la séquence du génome de la poule permettra d'établir une "cartographie virtuelle" des SNP obtenus, grâce à la grande conservation de synténie existant entre ces trois espèces

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study

Objectives; Our aim was to describe the burden of early dcSSc in terms of disability, fatigue and pain in the European Scleroderma Observational Study cohort, and to explore associated clinical features. Methods; Patients completed questionnaires at study entry, 12 and 24 months, including the HAQ disability index (HAQ-DI), the Cochin Hand Function Scale (CHFS), the Functional Assessment of Chronic Illness Therapy-fatigue and the Short Form 36 (SF36). Associates examined included the modified Rodnan skin score (mRSS), current digital ulcers and internal organ involvement. Correlations between 12-month changes were also examined. Results; The 326 patients recruited (median disease duration 11.9 months) displayed high levels of disability [mean (S.D.) HAQ-DI 1.1 (0.83)], with ‘grip’ and ‘activity’ being most affected. Of the 18 activities assessed in the CHFS, those involving fine finger movements were most affected. High HAQ-DI and CHFS scores were both associated with high mRSS (ρ = 0.34, P < 0.0001 and ρ = 0.35, P < 0.0001, respectively). HAQ-DI was higher in patients with digital ulcers (P = 0.004), pulmonary fibrosis (P = 0.005), cardiac (P = 0.005) and muscle involvement (P = 0.002). As anticipated, HAQ-DI, CHFS, the Functional Assessment of Chronic Illness Therapy and SF36 scores were all highly correlated, in particular the HAQ-DI with the CHFS (ρ = 0.84, P < 0.0001). Worsening HAQ-DI over 12 months was strongly associated with increasing mRSS (ρ = 0.40, P < 0.0001), decreasing hand function (ρ = 0.57, P < 0.0001) and increasing fatigue (ρ = −0.53, P < 0.0001). Conclusion; The European Scleroderma Observational Study highlights the burden of disability in early dcSSc, with high levels of disability and fatigue, associating with the degree of skin thickening (mRSS). Impaired hand function is a major contributor to overall disability

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).

OBJECTIVES: The rarity of early diffuse cutaneous systemic sclerosis (dcSSc) makes randomised controlled trials very difficult. We aimed to use an observational approach to compare effectiveness of currently used treatment approaches. METHODS: This was a prospective, observational cohort study of early dcSSc (within three years of onset of skin thickening). Clinicians selected one of four protocols for each patient: methotrexate, mycophenolate mofetil (MMF), cyclophosphamide or 'no immunosuppressant'. Patients were assessed three-monthly for up to 24 months. The primary outcome was the change in modified Rodnan skin score (mRSS). Confounding by indication at baseline was accounted for using inverse probability of treatment (IPT) weights. As a secondary outcome, an IPT-weighted Cox model was used to test for differences in survival. RESULTS: Of 326 patients recruited from 50 centres, 65 were prescribed methotrexate, 118 MMF, 87 cyclophosphamide and 56 no immunosuppressant. 276 (84.7%) patients completed 12 and 234 (71.7%) 24 months follow-up (or reached last visit date). There were statistically significant reductions in mRSS at 12 months in all groups: -4.0 (-5.2 to -2.7) units for methotrexate, -4.1 (-5.3 to -2.9) for MMF, -3.3 (-4.9 to -1.7) for cyclophosphamide and -2.2 (-4.0 to -0.3) for no immunosuppressant (p value for between-group differences=0.346). There were no statistically significant differences in survival between protocols before (p=0.389) or after weighting (p=0.440), but survival was poorest in the no immunosuppressant group (84.0%) at 24 months. CONCLUSIONS: These findings may support using immunosuppressants for early dcSSc but suggest that overall benefit is modest over 12 months and that better treatments are needed. TRIAL REGISTRATION NUMBER: NCT02339441

Extending in vitro digestion models to specific human populations: Perspectives, practical tools and bio-relevant information

[EN] Background In vitro digestion models show great promise in facilitating the rationale design of foods. This paper provides a look into the current state of the art and outlines possible future paths for developments of digestion models recreating the diverse physiological conditions of specific groups of the human population. Scope and approach Based on a collective effort of experts, this paper outlines considerations and parameters needed for development of new in vitro digestion models, e.g. gastric pH, enzymatic activities, gastric emptying rate and more. These and other parameters are detrimental to the adequate development of in vitro models that enable deeper insight into matters of food luminal breakdown as well as nutrient and nutraceutical bioaccessibility. Subsequently, we present an overview of some new and emerging in vitro digestion models mirroring the gastro-intestinal conditions of infants, the elderly and patients of cystic fibrosis or gastric bypass surgery. Key findings and conclusions This paper calls for synchronization, harmonization and validation of potential developments in in vitro digestion models that would greatly facilitate manufacturing of foods tailored or even personalized, to a certain extent, to various strata of the human population.Shani-Levi, C.; Alvito, P.; Andrés Grau, AM.; Assunção, R.; Barbera, R.; Blanquet-Diot, S.; Bourlieu, C.... (2017). Extending in vitro digestion models to specific human populations: Perspectives, practical tools and bio-relevant information. Trends in Food Science & Technology. 60:52-63. https://doi.org/10.1016/j.tifs.2016.10.017S52636